Latest News

16 June 2021
The Time To Act campaign, which aims to tackle the stalling of cancer treatment during the pandemic, was launched in May. Professor Antonino Spinelli, ESCP General Secretary, took part in the campaign event and is interviewed here by Nagendra Dudi-Venkata and Yongbo An from ESCP's SoMe Subcommittee.
14 June 2021
Cristián Gallardo interviews Soo Young Lee from Chonnam National University Hwasun Hospital in Korea in the run-up to ESCP's next Global Reach webinar 'Myths and Evidence in Diverticular Disease'.Total Neoadjuvant Chemotherapy or standard adjuvant chemotherapy for locally advanced rectal cancer?
10 June 2021
June’s paper of the month looks at the PRODIGE-23 trial, a randomised phase 3 clinical trial which sought to determine whether total neoadjuvant chemotherapy (TNT) before surgery improved disease-free survival (DFS) compared with standard preoperative chemoradiotherapy (CRT) in patients with locally advanced rectal cancer.
7 June 2021
Vittoria Bellato interviews Mr Shahnawaz Rasheed, Consultant Surgeon at The Royal Marsden, London, about his experience of robotic-assisted pelvic exenteration.
3 June 2021
Vittoria Bellato interviews Johannes Schultz about ESCP’s Guidelines for the Management of Diverticular Disease ahead of ESCP's next Global Reach webinar 'Myths and Evidence in Diverticular Disease'.Page 46 of 143